Hui Guo

3.1k total citations
93 papers, 2.0k citations indexed

About

Hui Guo is a scholar working on Molecular Biology, Surgery and Infectious Diseases. According to data from OpenAlex, Hui Guo has authored 93 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Molecular Biology, 25 papers in Surgery and 23 papers in Infectious Diseases. Recurrent topics in Hui Guo's work include SARS-CoV-2 and COVID-19 Research (13 papers), COVID-19 Clinical Research Studies (12 papers) and Renal Transplantation Outcomes and Treatments (11 papers). Hui Guo is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (13 papers), COVID-19 Clinical Research Studies (12 papers) and Renal Transplantation Outcomes and Treatments (11 papers). Hui Guo collaborates with scholars based in China, United States and Italy. Hui Guo's co-authors include Zhaohui Lu, Jinquan Wang, Changcheng Zheng, Catherine Z. Chen, Paul Shinn, Wei Zheng, Min Shen, Sam Michael, Mingming Fei and Xin Hu and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Journal of Immunology and PLoS ONE.

In The Last Decade

Hui Guo

87 papers receiving 2.0k citations

Peers

Hui Guo

ONCOL

CTM

Xiaofang Zhao China

Yong Feng China

Shasha Hu China

Michael Gosselin United States

Takaaki Nakamura Japan

Jiannan Feng China

Yung‐Hung Luo Taiwan

Donghong Yang China

Huabing Tan China

Ling Zhang United States

Xiaofang Zhao China

Hui Guo

909 ×1.2

488 ×0.7

302 ×1.1

ONCOL

231 ×0.9

59 ×0.2

CTM

Citations per year, relative to Hui Guo Hui Guo (= 1×) peers Xiaofang Zhao

Countries citing papers authored by Hui Guo

Since Specialization

Citations

This map shows the geographic impact of Hui Guo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hui Guo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hui Guo more than expected).

Fields of papers citing papers by Hui Guo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hui Guo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hui Guo. The network helps show where Hui Guo may publish in the future.

Co-authorship network of co-authors of Hui Guo

This figure shows the co-authorship network connecting the top 25 collaborators of Hui Guo. A scholar is included among the top collaborators of Hui Guo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hui Guo. Hui Guo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Liu, Huijie, Liang Yu, Jing Zhang, et al.. (2025). Chronic intermittent hypobaric hypoxia prevents pulmonary arterial hypertension through maintaining eNOS homeostasis. Archives of Biochemistry and Biophysics. 767. 110340–110340.

Shrimp, Jonathan H., John Janiszewski, Catherine Z. Chen, et al.. (2022). Suite of TMPRSS2 Assays for Screening Drug Repurposing Candidates as Potential Treatments of COVID-19. ACS Infectious Diseases. 8(6). 1191–1203. 6 indexed citations

Chen, Hengyu, Ming Yang, Haohao Huang, et al.. (2022). YTHDF1 promotes breast cancer progression by facilitating FOXM1 translation in an m6A-dependent manner. Cell & Bioscience. 12(1). 19–19. 80 indexed citations

Guo, Hui, Yinguang Fan, Zichen Song, et al.. (2021). The Cytokine Profiles and Immune Response Are Increased in COVID-19 Patients with Type 2 Diabetes Mellitus. Journal of Diabetes Research. 2021. 1–8. 35 indexed citations

Hu, Xin, Jonathan H. Shrimp, Hui Guo, et al.. (2021). Discovery of TMPRSS2 Inhibitors from Virtual Screening as a Potential Treatment of COVID-19. ACS Pharmacology & Translational Science. 4(3). 1124–1135. 44 indexed citations

Hu, Xin, Catherine Z. Chen, Miao Xu, et al.. (2021). Discovery of Small Molecule Entry Inhibitors Targeting the Fusion Peptide of SARS-CoV-2 Spike Protein. ACS Medicinal Chemistry Letters. 12(8). 1267–1274. 16 indexed citations

Liu, Fang, Hui Guo, Dong Xu, et al.. (2020). Clinical characteristics, CT signs, and pathological findings of Pyrrolizidine alkaloids-induced sinusoidal obstructive syndrome: a retrospective study. BMC Gastroenterology. 20(1). 30–30. 20 indexed citations

Zhu, Wei, Miao Xu, Catherine Z. Chen, et al.. (2020). Identification of SARS-CoV-2 3CL Protease Inhibitors by a Quantitative High-Throughput Screening. ACS Pharmacology & Translational Science. 3(5). 1008–1016. 152 indexed citations

Yang, Xiaopeng, et al.. (2020). Acute kidney injury and renal replacement therapy in COVID-19 patients: A systematic review and meta-analysis. International Immunopharmacology. 90. 107159–107159. 45 indexed citations

10.

Cheng, Xiang, Ying Wang, Jianbo Tian, et al.. (2019). SLC10A1 S267F variant influences susceptibility to HBV infection and reduces cholesterol level by impairing bile acid uptake. Journal of Viral Hepatitis. 26(10). 1178–1185. 9 indexed citations

11.

Le, Kehao, Hui Guo, Qiulei Zhang, et al.. (2019). Gene and lncRNA co-expression network analysis reveals novel ceRNA network for triple-negative breast cancer. Scientific Reports. 9(1). 15122–15122. 30 indexed citations

12.

Jiang, Fengchao, Limin Zhang, Wentao He, et al.. (2015). Targeting of MyD88 Homodimerization by Novel Synthetic Inhibitor TJ-M2010-5 in Preventing Colitis-Associated Colorectal Cancer. JNCI Journal of the National Cancer Institute. 108(4). djv364–djv364. 78 indexed citations

13.

Guo, Hui, Wei Chen, Jie Ming, et al.. (2015). Association between polymorphisms in cdc27 and breast cancer in a Chinese population. Tumor Biology. 36(7). 5299–5304. 6 indexed citations

14.

Tian, Ye, Chong Lu, Hui Guo, et al.. (2014). Effects of notch-1 down-regulation on malignant behaviors of breast cancer stem cells. Journal of Huazhong University of Science and Technology [Medical Sciences]. 34(2). 195–200. 9 indexed citations

15.

Cheng, Hongtao, Tao Huang, Wei Wang, et al.. (2013). Clinicopathological features of breast cancer with different molecular subtypes in chinese women. Journal of Huazhong University of Science and Technology [Medical Sciences]. 33(1). 117–121. 21 indexed citations

16.

Zhang, Shu, Ping Yang, Qilin Yu, et al.. (2012). Loss of Dicer Exacerbates Cyclophosphamide-Induced Bladder Overactivity by Enhancing Purinergic Signaling. American Journal Of Pathology. 181(3). 937–946. 50 indexed citations

17.

Cong, Wen‐Ming, Xiqi Hu, Yun-shan Tan, et al.. (2012). Expert consensus on the scheme of pathological diagnosis of primary liver cancer.. PubMed. 1(1). 12–12. 13 indexed citations

18.

Zhang, Jun, Jiashun Wang, Zhikun Zheng, et al.. (2012). Participation of autophagy in lung ischemia–reperfusion injury in vivo. Journal of Surgical Research. 182(2). e79–e87. 38 indexed citations

19.

Chen, Zhiqiang, Zhangqun Ye, Debo Kong, et al.. (2011). The construction of an oxalate-degrading intestinal stem cell population in mice: a potential new treatment option for patients with calcium oxalate calculus. Urological Research. 40(2). 131–141. 3 indexed citations

20.

Chen, Gang, Qian‐Yun Sun, Shiqian Shen, et al.. (2004). Improved suppression of circulating complement does not block acute vascular rejection of pig‐to‐rhesus monkey cardiac transplants. Xenotransplantation. 11(2). 123–132. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact